Evidence map›Paper›PMID 28434163›Full record

ReviewNeurochemical research2017

Biomarkers of Epileptogenesis: The Focus on Glia and Cognitive Dysfunctions.

Annamaria Vezzani, Rosaria Pascente, Teresa Ravizza

Abstract readReview
PubMed Publisher
In one paragraph

Review in Neurochemical research, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.4field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 30 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Frontiers in pharmacology · 2024
    Article
  9. The metabolic basis of epilepsy.Nature reviews. Neurology · 2022
    Review
  10. Ellagic acid and allopurinol decrease HExperimental brain research · 2022
    Article
  11. Review
  12. Review
  13. Review
  14. Review
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Annamaria VezzaniDepartment of Neuroscience, IRCCS-Istituto Di Ricerche Farmacologiche Mario Negri, Via G. La Masa, 19, 20156, Milan, Italy. annamaria.vezzani@marionegri.it.
Rosaria PascenteDepartment of Neuroscience, IRCCS-Istituto Di Ricerche Farmacologiche Mario Negri, Via G. La Masa, 19, 20156, Milan, Italy.
Teresa RavizzaDepartment of Neuroscience, IRCCS-Istituto Di Ricerche Farmacologiche Mario Negri, Via G. La Masa, 19, 20156, Milan, Italy.
Mario Negri Institute for Pharmacological Research · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The need to find measures that reliably predict the onset of epilepsy after injurious events or how the patient will respond to anti-seizure drugs led to intensive pre-clinical and clinical research to discover non-invasive biomarkers that could increase the sensitivity of existing clinical indicators. The use of experimental models of epileptogenesis and of drug-resistance is instrumental to select the most promising approaches to explore such biomarkers in the pre-clinical setting for further clinical validation. The approaches most frequently used to find clinically useful biomarkers of epileptogenesis include molecular brain imaging, EEG signal analysis and the measure of soluble molecules in biofluids which may reflect brain intrinsic events involved in epilepsy development. Among those, we focused our attention on proton magnetic resonance imaging (

Indexed as

AnimalsBiomarkersBrainCognitive DysfunctionEpilepsyHumansNeurogliaProton Magnetic Resonance SpectroscopyBiomarkersAstrocytesBiomarkerCo-morbidityEpilepsyImagingInflammation

Identifiers

PMID28434163
OpenAlexW2607399492

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.